Treatment for acute myocardial infarction. Overview of randomized clinical trials

European Heart Journal
S YusufM Coutinho

Abstract

This review summarizes the results of several pharmacological interventions that have been evaluated in the management of acute myocardial infarction. Of these, thrombolytic therapy, aspirin, beta-blockers and angiotensin converting enzyme inhibitors have all been proven to reduce mortality risk and the latter three classes of drugs have also been shown to reduce morbidity. Routine use of heparin or nitrates is not recommended although they may be useful in specific circumstances such as post-infarction angina or large infarcts. Drugs that have as yet not been shown to have a role in the routine management of acute myocardial infarction include Class I antiarrhythmic agents, magnesium and calcium antagonists. Management of patients with acute myocardial infarction can now be appropriately based on the evidence generated from well conducted randomized clinical trials and appropriate therapeutic choices based on such information can be expected to reduce their morbidity and mortality risks.

Citations

May 25, 2013·Clinical and Experimental Pharmacology & Physiology·Raquel N de La FuenteMaria-Cláudia Irigoyen
Aug 24, 2013·Clinical and Experimental Pharmacology & Physiology·Colleen J Thomas
Jul 18, 2015·Pharmacoepidemiology and Drug Safety·Hatem HamoodRonit Almog
Apr 27, 2001·Mayo Clinic Proceedings·W L Miller, G S Reeder
Dec 23, 2006·Clinical and Experimental Pharmacology & Physiology·Eugene Nalivaiko
Aug 7, 2004·Autonomic Neuroscience : Basic & Clinical·Pedro Paulo da Silva SoaresMaria Claudia Costa Irigoyen
Jan 24, 2006·Heart & Lung : the Journal of Critical Care·Vicente BertomeuEnrique González-Hernández
Mar 1, 1997·Lancet·J McMurray, D Murdoch
Oct 16, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Heidi L Lujan, Stephen E DiCarlo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.